Stock Screener · Library
TARSUS PHARMACEUTICALS, INC. financial statement history
Source-linked financial facts for TARSUS PHARMACEUTICALS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 178907000 | USD | 2023-03-17 | 2022 / FY | us-gaap:Assets | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 227863000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Assets | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 265491000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Assets | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 376991000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Assets | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 562158000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Assets | 10-K · 0001819790-26-000019 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 175952000 | USD | 2023-03-17 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 225375000 | USD | 2024-02-27 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 256131000 | USD | 2025-02-25 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 356705000 | USD | 2026-02-23 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 522782000 | USD | 2026-02-23 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001819790-26-000019 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 171332000 | USD | 2023-03-17 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 71660000 | USD | 2024-02-27 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 224947000 | USD | 2025-02-25 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 94818000 | USD | 2026-02-23 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 183640000 | USD | 2026-02-23 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001819790-26-000019 |
Inventory
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2022-12-31 | 0 | USD | 2024-02-27 | 2023 / FY | us-gaap:InventoryNet | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 3107000 | USD | 2025-02-25 | 2024 / FY | us-gaap:InventoryNet | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 2620000 | USD | 2026-02-23 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 4372000 | USD | 2026-02-23 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0001819790-26-000019 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 755000 | USD | 2023-03-17 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 957000 | USD | 2024-02-27 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 1468000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 2314000 | USD | 2026-02-23 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 11665000 | USD | 2026-02-23 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001819790-26-000019 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 12177000 | USD | 2023-03-17 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 34963000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 68503000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 152457000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 218732000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001819790-26-000019 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 11478000 | USD | 2023-03-17 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 15429000 | USD | 2024-02-27 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 36936000 | USD | 2025-02-25 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 80612000 | USD | 2026-02-23 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 135695000 | USD | 2026-02-23 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001819790-26-000019 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 0 | USD | 2023-03-17 | 2022 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001819790-23-000007 |
| As of 2022-12-31 | 19434000 | USD | 2024-02-27 | 2023 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001819790-24-000018 |
| As of 2023-12-31 | 29819000 | USD | 2025-02-25 | 2024 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001819790-25-000011 |
| As of 2024-12-31 | 71845000 | USD | 2026-02-23 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 72438000 | USD | 2026-02-23 | 2025 / FY | us-gaap:LongTermDebtNoncurrent | 10-K · 0001819790-26-000019 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 166730000 | USD | 2025-02-25 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001819790-25-000011 |
| As of 2022-12-31 | 192900000 | USD | 2026-02-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001819790-26-000019 |
| As of 2023-12-31 | 196988000 | USD | 2026-02-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001819790-26-000019 |
| As of 2024-12-31 | 224534000 | USD | 2026-02-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001819790-26-000019 |
| As of 2025-12-31 | 343426000 | USD | 2026-02-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001819790-26-000019 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 57027000 | USD | 2023-03-17 | 2022 / FY | us-gaap:Revenues | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | 25816000 | USD | 2025-02-25 | 2024 / FY | us-gaap:Revenues | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | 17447000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Revenues | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | 182953000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Revenues | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | 451360000 | USD | 2026-02-23 | 2025 / FY | us-gaap:Revenues | 10-K · 0001819790-26-000019 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 41712000 | USD | 2023-03-17 | 2022 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | 42624000 | USD | 2025-02-25 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | 50312000 | USD | 2026-02-23 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | 53386000 | USD | 2026-02-23 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | 64322000 | USD | 2026-02-23 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001819790-26-000019 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -12157000 | USD | 2023-03-17 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | -62712000 | USD | 2025-02-25 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | -143158000 | USD | 2026-02-23 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | -120569000 | USD | 2026-02-23 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | -70969000 | USD | 2026-02-23 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001819790-26-000019 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -13827000 | USD | 2023-03-17 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | -62091000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | -135893000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | -115554000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | -66418000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001819790-26-000019 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -0.67 | USD/shares | 2023-03-17 | 2022 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | -2.52 | USD/shares | 2025-02-25 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | -4.62 | USD/shares | 2026-02-23 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | -3.07 | USD/shares | 2026-02-23 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | -1.59 | USD/shares | 2026-02-23 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001819790-26-000019 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 3748000 | USD | 2023-03-17 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | -49030000 | USD | 2025-02-25 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | -117493000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | -83027000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | -12451000 | USD | 2026-02-23 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001819790-26-000019 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 586000 | USD | 2023-03-17 | 2022 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001819790-23-000007 |
| 2022-01-01 to 2022-12-31 | 506000 | USD | 2025-02-25 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001819790-25-000011 |
| 2023-01-01 to 2023-12-31 | 1502000 | USD | 2026-02-23 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001819790-26-000019 |
| 2024-01-01 to 2024-12-31 | 1567000 | USD | 2026-02-23 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001819790-26-000019 |
| 2025-01-01 to 2025-12-31 | 9859000 | USD | 2026-02-23 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001819790-26-000019 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1819790
- Ticker in native snapshot
- TARS
- Reported numeric facts
- 79
- Units present
- USD · USD/shares